参考文献/References:
[1] 祝珊珊,秦飞,陈仲巍,等.索拉菲尼对肝癌HepG2细胞凋亡、耐药及PTEN蛋白表达的影响[J].中国药理学通报,2020,36(11):1532-1536.
[2] 刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-14.
[3] 郭俊霞,魏晓华.乙肝肝硬化患者合并原发性肝癌的危险因素及预后分析[J].陕西医学杂志,2019,48(7):850-852.
[4] DIXON S J,LEMBERG K M,LAMPRECHT M R,et al.Ferroptosis:An iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
[5] WANG Y F,ZHAO M,ZHAO L N,et al.HBx-Induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression[J].Cancer Res,2023,83(7):1048-1061.
[6] HU W Y,ZHOU C T,JING Q G,et al.FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis[J].Cancer Cell Int,2021,21(1):709.
[7] 刘湘慧,斯韬,梁婷,等.铁死亡发生机制及其在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(3):354-357.
[8] 张爽爽,殷晓轩.原发性肝癌的中医药和免疫治疗研究进展[J].中西医结合肝病杂志,2022,32(7):669-672.
[9] 李武浩,许尤琪.中医药防治肝动脉灌注化疗相关不良反应研究进展[J].陕西中医,2022,43(5):673-676.
[10] YU H T,GUO P Y,XIE X Z,et al.Ferroptosis,a new form of cell death,and its relationships with tumourous diseases[J].J Cell Mol Med,2017,21(4):648.
[11] 鲁孟丽,邱彤,詹斯文,等.中药活性成分单用及联合化疗药物抗肿瘤研究进展[J].中国医院药学杂志,2023,43(4):450-457.
[12] DU J,WANG T T,LI Y C,et al.DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin[J].Free Radical Biology and Medicine,2019,131:356-369.
[13] GAO M H,MONIAN P,JIANG X J,et al.Metabolism and iron signaling in ferroptotic cell death[J].Oncotarget,2015,6(34):35145-35146.
[14] WANG C Y,BABITT J L.Liver iron sensing and body iron homeostasis[J].Blood,2019,133(1):18-29.
[15] SORRENTINO P,D'ANGELO S,FERBO U,et al.Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis[J].Hepatol,2009,50:351-357.
[16] CHENG X X,ZHANG J L,XIAO Y C,et al.Mitochondrial regulation of ferroptosis in cancer therapy[J].Mol Sci,2023,24(12):10037.
[17] PANAGOPOULOS D J,KARABARBOUNIS A,YAKYMENKO I,et al.Human made electromagnetic fields:Ion forced oscillation and voltage gated ion channel dysfunction,oxidative stress and DNA damage(Review)[J].Oncol,2021,59(5):92.
[18] 程峰,张庸,王祥,等.谷胱甘肽过氧化物酶GPX4在铁死亡中的作用与机制研究进展[J].现代肿瘤医学,2021,29(7):1254-1258.
[19] LI J,JIA Y C,DING Y X,et al.The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks[J].Biol Sci,2023,19(9):2756-2771.
[20] STOCKWELL B R.Ferroptosis turns 10:Emerging mechanisms,physiological functions,and therapeutic applications[J].Cell,2022,185(14):2401-2421.
[21] KUANG F M,LIU J,TANG D L,et al.Oxidative damage and antioxidant defense in ferroptosis[J].Front Cell Dev Biol,2020,8:586578.
[22] SHINTOKU R,TAKIGAWA Y,YAMADA K,et al.Lipo-xygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3[J].Cancer Sci,2017,108(11):2187-2194.
[23] QIU Y M,CAO Y,CAO W J,et al.The application of ferroptosis in diseases[J].Pharmacol Res,2020,159:104919.
[24] 徐巧笑,胡振斌,莫莎莎,等.从“虚、毒、瘀”浅谈原发性肝癌病机和治疗[J].陕西中医,2023,44(10):1431-1434.
[25] KISSELEVA T,BRENNER D A.The crosstalk between hepatocytes,hepatic macrophages,and hepatic stellate cells facilitates alcoholic liver disease[J].Cell Metab,2019,30(5):850-852.
[26] 李艳纯,周怡,王鑫,等.二氢青蒿素通过诱导铁死亡抑制肝癌细胞生长[J].中国生物化学与分子生物学报,2019,35(12):1361-1366.
[27] 张楠.栀子关键成分通过铁死亡路径改善酒精性肝病、肝癌及其他肿瘤的药理分析[D].太原:山西师范大学,2022.
[28] LAN T,WANG W,ZENG X X,et al.Saikosaponin a triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression[J].Biochemical and Biophysical Research Communications,2023,674:10-18.
[29] 洪婷,王依蕾,曾海荣,等.葫芦素B诱导细胞铁死亡抑制肝癌Huh-7细胞增殖的机制[J].中国药理学通报,2023,39(4):638-645.
[30] 袁靖涛.华泽兰有效部位EChLESs诱导凋亡及铁死亡抗肝癌作用研究[D].杭州:浙江中医药大学,2023.
[31] 刘金丽,佟雷,罗烨,等.隐丹参酮可能具有诱导人肝癌HepG2细胞铁死亡的作用[J].中国医学科学院学报,2021,43(3):366-370.
[32] SUI M,JIANG X F,CHEN J,et al.Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway[J].Biomed Pharmacother,2018,106:125-133.
[33] ZAO X B,CAO X,LIANG Y J,et al.The chinese herbal Kangxian Yiai formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosis[J].Pharmacological Research-Modern Chinese Medicine,2023,8:1-16.
[34] 王智槟,郜文辉,杨仁义,等.基于P53/xCT/GPX4通路探讨实脾消积方干预糖代谢异常肝癌细胞铁死亡的机制研究[J].中国病理生理杂志,2023,39(6):1061-1069.
[35] 许健,詹月萍,蒋元烨,等.α-常春藤皂苷的抗肿瘤药理作用研究进展[J].实用肿瘤学杂志,2019,33(6):553-556.
[36] 韩松峰,关璐璐,李世朋,等.α-常春藤皂苷诱导肝癌Bel-7402细胞铁死亡的作用机制[J].现代肿瘤医学,2022,30(19):3467-3472.
[37] 周佳林,黄雪云,刘翔,等.基于系统药理学探讨半夏-天南星调控铁死亡、细胞自噬和凋亡治疗原发性肝癌的作用机制[J].浙江中医药大学学报,2023,47(9):1087-1099.
[38] 杨晶.基于GPX4通路探讨固本消积方对人肝癌HepG2细胞铁死亡的作用机制[D].长沙:湖南中医药大学,2023.
相似文献/References:
[1]肖 岚,朱 宏,张 婷,等.董克礼教授治疗原发性肝癌临床经验*[J].陕西中医,2020,(11):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
XIAO Lan,ZHU Hong,ZHANG Ting,et al.Experience of professor DONG Keli for treating primary liver cancer[J].,2020,(2):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
[2]王 军,徐建良,杜燕红.扶正祛邪汤对肝癌模型大鼠肠道菌群微生态环境的作用研究[J].陕西中医,2021,(2):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
WANG Jun,XU Jianliang,DU Yanhong.Effect of Fuzheng Quxie decoction on intestinal microflora microecological environment of liver cancer model rats[J].,2021,(2):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
[3]朱玉辉,柴 劲.黄芪补气汤联合还原型谷胱甘肽对肝癌介入治疗后患者肝功能、氧化应激及炎症的影响[J].陕西中医,2021,(5):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
ZHU Yuhui,CHAI Jin.Effect of Huangqi Buqi decoction combined with reduced glutathione on liver function,oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma[J].,2021,(2):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
[4]刘振方,孙巧玉,孟祥彩,等.黄芩素下调微小RNA-130a抑制肝癌细胞侵袭机制研究[J].陕西中医,2021,(12):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
LIU Zhenfang,SUN Qiaoyu,MENG Xiangcai,et al.Study on mechanism of baicalein down-regulating miR-130a to inhibit hepatocellular carcinoma invasion[J].,2021,(2):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
[5]李武浩,许尤琪.中医药防治肝动脉灌注化疗相关不良反应研究进展[J].陕西中医,2022,(5):673.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.031]
LI Wuhao,XU Youqi.Clinical research progress of traditional Chinese medicine on the prevention and treatment of related adverse reaction of hepatic artery infusion chemotherapy[J].,2022,(2):673.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.031]
[6]陈抒鹏,王思梦,唐娜娜,等.基于浊邪与铁死亡相关性探析动脉粥样硬化之病机[J].陕西中医,2022,(11):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
CHEN Shupeng,WANG Simeng,TANG Nana,et al.Exploring the pathogenesis of atherosclerosis based on the correlation between turbid pathogens and ferroptosis[J].,2022,(2):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
[7]陈 嵘,李淑敏,李旭华,等.软坚散结方调控小鼠HIF-1α 糖酵解分子转导抑制肝肿瘤细胞增殖机制研究[J].陕西中医,2023,(7):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
CHEN Rong,LI Shumin,LI Xuhua,et al.Mechanism study on Ruanjian Sanjie prescription inhibit proliferation of liver cancer cells through regulating HIF-1α pathway[J].,2023,(2):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
[8]刘 鹏,陈青山,杨建波.柴胡疏肝散加减联合射频消融治疗肝癌疗效研究[J].陕西中医,2023,(7):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
LIU Peng,CHEN Qingshan,YANG Jianbo.Curative effect study on Chaihu Shugan powder combined with radiofrequency ablation for liver cancer[J].,2023,(2):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
[9]张宏生,林月洁,陆凤娟.血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证疗效研究[J].陕西中医,2023,(7):897.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
ZHANG Hongsheng,LIN Yuejie,LU Fengjuan.Clinical study on modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets in treatment of liver cancer pain of Yuxue Neizu syndrome[J].,2023,(2):897.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
[10]胡哲君,汤穆浛,张 锐,等.基于“肝病实脾”理论探讨逍遥散对肝纤维化大鼠肝星状细胞铁死亡的影响[J].陕西中医,2024,(2):159.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.003]
HU Zhejun,TANG Muhan,ZHANG Rui,et al.Effect of Xiaoyao powder on ferroptosis of hepatic stellate cells in rats with liver fibrosis based on the theory of “treating liver by nourishing spleen”[J].,2024,(2):159.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.003]